ContributorsPublishersAdvertisers

The Evolution of Therapy Sequencing in Advanced Bladder Cancer

cancernetwork.com
 2022-01-12

Cover picture for the articleDaniel Petrylak, MD: It’s going to be very interesting to see how the field develops over the next several years. This is going to be a challenge for clinicians because we do have the FDA approval of nivolumab as adjuvant therapy for 1 year in those patients who’ve undergone cystectomy. T2...

www.cancernetwork.com

Comments / 0

Comments / 0